NEW YORK, Aug. 13, 2021 /PRNewswire/ -- The global bone growth stimulation devices market is expected to grow by USD 380.59 million during 2021-2025, according to Technavio. The report provides an in-depth analysis of the competitive scenario with vendors holding dominant market positions including Bioventus LLC (US), BTT Health GmbH (Germany), Colfax Corp.(US), Fintek Bio Electric Inc.(Canada), IGEA Spa (Italy), Medtronic Plc (Ireland), Orthofix Medical Inc.(US), Ossatec Benelux Ltd. (The Netherlands), Stimulate Health Inc.(Canada), and Zimmer Biomet Holdings Inc. (US).
For Right Perspective & Competitive Insights, Use Our Competitive Benchmarking and Analysis.
The bone growth stimulation devices market is driven by bone degeneration in the elderly population, an increase in product launches, and growing orthopedic conditions and surgical cases. These factors are expected to lead the bone growth stimulation devices market to grow at a healthy CAGR of 5.41%. However, stringent regulatory guidelines might create a hindrance to the growth of the market.
Access our detailed 120-page report on "Bone Growth Stimulation Devices Market by Product (External and Internal) and Geography (North America, Europe, Asia, and ROW) - Forecast and Analysis 2021-2025":
Technavio is a leading global technology research and advisory company. Their research and analysis focuses on emerging market trends and provides actionable insights to help businesses identify market opportunities and develop effective strategies to optimize their market positions. With over 500 specialized analysts, Technavio's report library consists of more than 17,000 reports and counting, covering 800 technologies, spanning across 50 countries. Their client base consists of enterprises of all sizes, including more than 100 Fortune 500 companies. This growing client base relies on Technavio's comprehensive coverage, extensive research, and actionable market insights to identify opportunities in existing and potential markets and assess their competitive positions within changing market scenarios.